- Home
- APT vs CRVO Comparison
APT vs CRVO Comparison
Compare APT & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- CRVO
- Stock Information
- Founded
- APT 1983
- CRVO 2001
- Country
- APT Canada
- CRVO United States
- Employees
- APT N/A
- CRVO N/A
- Industry
- APT
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- APT
- CRVO Health Care
- Exchange
- APT Nasdaq
- CRVO Nasdaq
- Market Cap
- APT 61.6M
- CRVO 69.3M
- IPO Year
- APT 1995
- CRVO N/A
- Fundamental
- Price
- APT $4.56
- CRVO $7.62
- Analyst Decision
- APT
- CRVO Strong Buy
- Analyst Count
- APT 0
- CRVO 8
- Target Price
- APT N/A
- CRVO $25.57
- AVG Volume (30 Days)
- APT 42.1K
- CRVO 176.8K
- Earning Date
- APT 05-08-2025
- CRVO 05-12-2025
- Dividend Yield
- APT N/A
- CRVO N/A
- EPS Growth
- APT 2.28
- CRVO N/A
- EPS
- APT 0.36
- CRVO N/A
- Revenue
- APT $58,180,000.00
- CRVO $9,308,215.00
- Revenue This Year
- APT N/A
- CRVO N/A
- Revenue Next Year
- APT N/A
- CRVO N/A
- P/E Ratio
- APT $12.84
- CRVO N/A
- Revenue Growth
- APT N/A
- CRVO 15.14
- 52 Week Low
- APT $4.06
- CRVO $1.80
- 52 Week High
- APT $6.44
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- APT 47.84
- CRVO 42.83
- Support Level
- APT $4.25
- CRVO $7.20
- Resistance Level
- APT $5.16
- CRVO $8.60
- Average True Range (ATR)
- APT 0.23
- CRVO 0.56
- MACD
- APT 0.01
- CRVO -0.08
- Stochastic Oscillator
- APT 34.07
- CRVO 33.15
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.